Loading...
Loading...
Low-dose, frequent chelation protocol using DMSA and/or ALA (alpha-lipoic acid) on precise timing schedules to prevent mercury redistribution.
72/100
Andrew Cutler
6 months to 3+ years (ongoing rounds)
9 phases
3 targeted
Low-dose, frequent chelation protocol using DMSA and/or ALA (alpha-lipoic acid) on precise timing schedules to prevent mercury redistribution. Based on half-life chemistry to maintain steady chelator levels. Emphasizes slow, safe removal over months/years.
Requires strict adherence to timing (set alarms overnight). DMSA 4-hour half-life, ALA 3-hour. Never use ALA without DMSA if amalgams present. Controversial in mainstream medicine.
About Evidence Score
The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.
Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.